Triple Combination Formulation for Treatment of Chronic Pain.
journal contribution
posted on 2019-10-15, 00:00authored byA. Vania Apkarian, Kasturi Halder, Maria Virginia Centeno, Suhail Alam
The disclosure relates to use of a triple formulation comprising a histone deacytlase, a cyclodextrin and polyethylene glycol or propylene glycol, and in the treatment and management of chronic pain.
History
Alt Title
US Patent Application Publication
Date Modified
2019-10-15
Contributor
University of Notre Dame and Northwestern University